Advances in bioprinting are fast and exciting: As you can read in this paper, it’s now possible to use living bacteria in ink. It allows the creation of complex actives material very useful in healthcare, for exemple, but also in 3D cell co-cultures. Article presents us the enormous potential of this technology in many other domains.

In HCS Pharma we are very interested by this evolution and we are working on our biomimetic hydrogel scaffold BIOMIMESYS® to propose a great product in few months.BIOMIMESYS®!

A group of ETH researchers led by Professor André Studart, Head of the Laboratory for Complex Materials, has now introduced a new 3D printing platform that works using living matter. The researchers developed a bacteria-containing ink that makes it possible to print mini biochemical factories with certain properties, depending on which species of bacteria the scientists put in the ink.

Source: 3D-printed minifactories | ETH Zurich

HCS Pharma, expert in cellular imaging & in vitro assay development for High Content Screening (HCS) & Analysis (HCA) has just acquired BIOMIMESYS® Technology, a biomimetic hydrogel scaffold based on biofunctionalized hyaluronic acid with extracellular matrix components for 3D cell culture.

If you have already used BIOMIMESYS® products, be aware that they will be available again in early 2018! If you do not know yet this technology, please let us know your interest.

Using BIOMIMESYS® Technology, HCS Pharma will also provide its expertise in HCS/HCA to evaluate the efficacy, mode of action, and safety of your therapeutic molecules on 3D cell models.

Ask us for a TC to know more about our services and products.

BIOMIMESYS® Plates’ assets:

  • Natural biofunctionnalized scaffold
  • Ready-to-use and easy to handle for highly reproducible experiments
  • Compatible with HTS & HCS
  • Use also for long term cultures & in vivo transplantation
  • Ease of cell retrieval, PCR & WB analysis

Whether in the analytical or in the production field, quality and homogeneity of culture media batches in the course of time has a real impact in laboratories. These media may include more than 300 components including proteins, lipids, as well as hormones, and other molecules. Moreover, their cost has a real impact on the budgeting of research projects.

Find out in this article from the challenges of producing alternatives complex environments to replace serum in the case of the production of biosimilars (either during the production or at the moment of purification).
This problems occurring also in cell cultures laboratories, some companies are seeking to develop alternatives to serums, reproducing as faithfully as possible biological activity …



%d bloggers like this: